HOME >> MEDICINE >> NEWS
Zengen's new study reviews novel approach to control inflammation using melanocortin receptors

WOODLAND HILLS, Calif. (March 3, 2004) Zengen, Inc. announced today that its researchers have discovered that activation of melanocortin receptors (MCR) subtypes MC1R and MC3R could be a novel strategy to control inflammatory disorders.

The findings, "Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation," appear in the March 2004 issue of Pharmacological Reviews, a publication of the American Society for Pharmacology and Experimental Therapeutics (ASPET).

"MCR activation causes a collective reduction of the major molecules involved in the inflammatory process," said Anna Catania, M.D., professor of endocrinology, School of Internal Medicine, University of Milan and lead author of the study. "This discovery is significant because it shows that treatment with melanocortin peptides doesn't abolish the inflammatory response but instead modulates it. An advantage of melanocortins in the treatment of inflammation is that their influences are broad and are not restricted to a specific mediator or chemical pathway."

Recognition and cloning of five melanocortin receptors has greatly improved understanding of peptide-target cell interactions. Preclinical investigations indicate that activation of certain MCR subtypes, primarily MC1R and MC3R, could be useful in treatment of localized and systemic inflammatory disorders. These include: organ transplantation, chronic inflammatory diseases, acute inflammation, inflammation within the brain and neurogenerative disorders, peripheral neuropathies, systemic host reactions, ischemia and reperfusion injury and infections.

"The study results also indicate that certain melanocortin peptides have antimicrobial effects," said James Lipton, Ph.D., chief scientific officer and director of Zengen and study author. "Unlike corticosteroids, melanocortins do not reduce microbial killing activity, but enhance it. We are encouraged by these findings and will continue our res
'"/>


3-Mar-2004


Page: 1 2

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. UMaine study looks at infants and chronic nighttime crying
3. Chronic pain treatments more effective when taken together, new study shows
4. UNC study: Most N.C. family practitioners engage in unrecognized community service
5. New study in Nature demonstrates protection against cell death during heart attack
6. UCSF study offers insight into human circadian rhythms
7. International breast cancer prevention study launches in the United States and Canada
8. UW study shows blacks and Latinos are more satisfied with physicians of the same race
9. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
10. Advertising by academic medical centers may risk eroding public trust, says study
11. Fat may promote inflammation, new study suggests

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2019)... ... May 23, 2019 , ... In ... College, Altus Assessments has published new research in an academic journal, Academic Medicine, ... potential of increasing the racial and ethnic diversity of incoming medical students. , ...
(Date:5/23/2019)... SAN JOSE, Calif. (PRWEB) , ... May 23, 2019 , ... ... Rx IP Cores seamlessly integrated with its MIPI C-PHY v.1.2 IP supporting speeds ... per lane) and D-PHY v2.0 supporting speeds of upto 4.5 Gbps data rate per ...
(Date:5/23/2019)... ... 2019 , ... Join Dr. Ashok Srivastava, CEO & CMO at ClinFomatrix and ... at OmniComm Systems, Inc. , in a live webinar on Tuesday, ... benefits of visual patient profiles. Together, the two speakers bring years of experience in ...
(Date:5/23/2019)... Ariz. (PRWEB) , ... May 23, 2019 , ... ... Programs and Potomac Pathways are joining forces to turn the tide in the ... called Potomac Programs and signifies Embark’s commitment to community, outpatient, and home-based care. ...
(Date:5/22/2019)... ... 2019 , ... Impact Advisors , a leading provider of clinical, revenue ... been named to Becker’s Hospital Review’s 150+ Top Places to Work in Healthcare list. ... , “It is a great honor to be named to Becker’s 150+ Top ...
Breaking Medicine News(10 mins):
(Date:5/22/2019)... ... 2019 , ... On Thursday, May 23rd, AT&T’s Xandr will ... from 6-9 pm titled "Finding My Superpower: Stories from the Disability Community." This ... honest perspectives on disability, its unique challenges, and finding one's surprising power. , ...
(Date:5/22/2019)... ... 2019 , ... Americans can save more money on generic drugs at U.S. ... prices on the top-selling generic drugs. Eighty-eight percent of the top prescribed generics were ... lower at Canadian and other international online pharmacies than in the U.S. ...
(Date:5/22/2019)... BEACH, Fla. (PRWEB) , ... May 22, 2019 , ... Vib has announced the release ... to know about CBD vaping for beginners and explains some of the benefits it offers. ... was ‘to quit smoking’ the long-term vaping community is finally realizing that there are lots ...
Breaking Medicine Technology:
Cached News: